Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dzwonczyk

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1993
Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalimG J Grover, P G Sleph, S Dzwonczyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat heartsG J Grover, S Dzwonczyk, P G Sleph, et al.
Cardiovascular Drugs and Therapy|April 1, 1990
The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogsG J Grover, S Dzwonczyk, C S Parham, et al.
The American Journal of Physiology|October 1, 1994
Pyruvate increases threshold for preconditioning in globally ischemic rat heartsC A Sargent, S Dzwonczyk, P Sleph, et al.
Journal of Cardiovascular Pharmacology|August 1, 1992
Effect of calmodulin and protein kinase C inhibitors on globally ischemic rat heartsC A Sargent, P G Sleph, S Dzwonczyk, et al.
Journal of Cardiovascular Pharmacology|October 1, 1993
Protective effect of serotonin (5-HT2) receptor antagonists in ischemic rat heartsG J Grover, C A Sargent, S Dzwonczyk, et al.
The American Journal of Physiology|September 1, 1996
Preconditioning is not abolished by the delayed rectifier K+ blocker dofetilideG J Grover, A J D'Alonzo, S Dzwonczyk, et al.
Journal of Cardiovascular Pharmacology|January 1, 1997
Glyburide-reversible cardioprotective effects of BMS-180448: functional and energetic considerationsG J Grover, P G Sleph, S Dzwonczyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agentsC A Sargent, M A Smith, S Dzwonczyk, et al.
Journal of Cardiovascular Pharmacology|October 1, 1993
Cardioprotective effects of the cyanoguanidine potassium channel opener P-1075C A Sargent, P G Sleph, S Dzwonczyk, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1993
Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalimG J Grover, P G Sleph, S Dzwonczyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat heartsG J Grover, S Dzwonczyk, P G Sleph, et al.
Cardiovascular Drugs and Therapy|April 1, 1990
The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogsG J Grover, S Dzwonczyk, C S Parham, et al.
The American Journal of Physiology|October 1, 1994
Pyruvate increases threshold for preconditioning in globally ischemic rat heartsC A Sargent, S Dzwonczyk, P Sleph, et al.
Journal of Cardiovascular Pharmacology|August 1, 1992
Effect of calmodulin and protein kinase C inhibitors on globally ischemic rat heartsC A Sargent, P G Sleph, S Dzwonczyk, et al.
Journal of Cardiovascular Pharmacology|October 1, 1993
Protective effect of serotonin (5-HT2) receptor antagonists in ischemic rat heartsG J Grover, C A Sargent, S Dzwonczyk, et al.
The American Journal of Physiology|September 1, 1996
Preconditioning is not abolished by the delayed rectifier K+ blocker dofetilideG J Grover, A J D'Alonzo, S Dzwonczyk, et al.
Journal of Cardiovascular Pharmacology|January 1, 1997
Glyburide-reversible cardioprotective effects of BMS-180448: functional and energetic considerationsG J Grover, P G Sleph, S Dzwonczyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agentsC A Sargent, M A Smith, S Dzwonczyk, et al.
Journal of Cardiovascular Pharmacology|October 1, 1993
Cardioprotective effects of the cyanoguanidine potassium channel opener P-1075C A Sargent, P G Sleph, S Dzwonczyk, et al.
Pageof 4